Associate Christopher Swift was quoted in an article in The Washington Post on February 10, 2014 titled, “Al-Qaeda’s expulsion of Islamist group in Syria prompts U.S. debate,” following his testimony on February 4, 2014 before the U.S. House of Representatives Armed Services Committee. The 2001 Authorization for the Use of Military Force (AUMF) – the law giving the president the authority to attack al-Qaeda affiliates – is now under review due to the emerging dissension among formerly affiliated terror groups. In response to the question of definition, Swift said, “The goal here is not to narrow the scope of the AUMF or to expand the scope of the AUMF, but to align our ways, means and laws in such a way that we can achieve the ends that we’re after.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”